Royal Bank of Canada’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-56,713
Closed -$5.71M 6733
2014
Q4
$5.71M Sell
56,713
-117,727
-67% -$9.15M ﹤0.01% 1585
2014
Q3
$11.6M Buy
174,440
+20,806
+14% +$1.37M 0.01% 1117
2014
Q2
$10.7M Buy
153,634
+7,226
+5% +$491K 0.01% 1185
2014
Q1
$10.7M Sell
146,408
-2,976
-2% -$222K 0.01% 1116
2013
Q4
$10.3M Sell
149,384
-60,556
-29% -$3.92M 0.01% 1176
2013
Q3
$13.3M Buy
209,940
+192,920
+1,133% +$11.7M 0.01% 963
2013
Q2
$821K Buy
+17,020
New +$836K ﹤0.01% 2735

Royal Bank of Canada's CBST Position: Q1 2015 in Review

Royal Bank of Canada sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 56,713 shares — an estimated $5.71M sold.

Royal Bank of Canada first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $13.3M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Royal Bank of Canada reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 56,713 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $5.71M.
  • Royal Bank of Canada first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Royal Bank of Canada's CUBIST PHARMACEUTICALS INC position peaked at $13.3M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Royal Bank of Canada's 13F filing for Q1 2015, filed 15 May 2015.